EUVIMEDEUVIMED entdecken
Crossref

Discovery of SARS‐CoV‐2 Inhibitors Featuring Novel Histidine α ‐Nitrile Motif

Nilu Vijay Gone, Mohammed Ghalib Enayathullah, Jessie Thomas, Parth Rathee, Rajeev Prabhakar, Kiran Kumar Bokara, Gangadhar J Sanjayan iD

Chemistry & Biodiversity · 2023

DOI: 10.1002/cbdv.202300957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Nilu Vijay Gone und 6 weiteren Autor:innen. Beteiligte Einrichtung: Organic Chemistry Division, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune, 411008, India. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit nennt 56 Literaturangaben. Gefördert von: CSIR, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As COVID‐19 infection caused severe public health concerns recently, the development of novel antivirals has become the need of the hour. Main protease (M pro ) has been an attractive target for antiviral drugs since it plays a vital role in polyprotein processing and virus maturation. Herein we report the discovery of a novel class of inhibitors against the SARS‐CoV‐2, bearing histidine α ‐nitrile motif embedded on a simple dipeptide framework. In‐vitro and in‐silico studies revealed that the histidine α ‐nitrile motif envisioned to target the M pro contributes to the inhibitory activity. Among a series of dipeptides synthesized featuring this novel structural motif, some dipeptides displayed strong viral reduction (EC 50 =0.48 μM) with a high selectivity index, SI>454.54. These compounds also exhibit strong binding energies in the range of −28.7 to −34.2 Kcal/mol. The simple dipeptide structural framework, amenable to quick structural variations, coupled with ease of synthesis from readily available commercial starting materials are the major attractive features of this novel class of SARS‐CoV‐2 inhibitors. The histidine α ‐nitrile dipeptides raise the hope of discovering potent drug candidates based on this motif to fight the dreaded SARS‐CoV‐2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansHistidineProtease InhibitorsMolecular Docking SimulationMolecular Dynamics SimulationViral Nonstructural ProteinsDipeptidesAntiviral Agents

Stichwörter der Autor:innen

Mpro (main protease)SARS-CoV-2dipeptide inhibitorshistidine α-nitrilemolecular dynamics

Substanzen

HistidineProtease InhibitorsViral Nonstructural ProteinsDipeptidesAntiviral Agents

Autor:innen und Institutionen

  • Organic Chemistry Division, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune, 411008, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Annexe-II, Medical Biotechnology Complex, CSIR-Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad, Telangana, 500007, India.
  • Department of Chemistry, University of Miami, Coral Gables, FL, USA.

ORCID-Profile: Gangadhar J Sanjayan

Förderung

  • CSIR
  • National Science Foundation

Zitieren

APA

Vijay Gone, N., Ghalib Enayathullah, M., Thomas, J., Rathee, P., Prabhakar, R., Kumar Bokara, K., & Sanjayan, G. J. (2023). Discovery of SARS‐CoV‐2 Inhibitors Featuring Novel Histidine α ‐Nitrile Motif. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202300957

Vancouver

Vijay Gone N, Ghalib Enayathullah M, Thomas J, Rathee P, Prabhakar R, Kumar Bokara K, et al. Discovery of SARS‐CoV‐2 Inhibitors Featuring Novel Histidine α ‐Nitrile Motif. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202300957

BibTeX
@article{VijayGone2023,
  author = {Vijay Gone, Nilu and Ghalib Enayathullah, Mohammed and Thomas, Jessie and Rathee, Parth and Prabhakar, Rajeev and Kumar Bokara, Kiran and Sanjayan, Gangadhar J},
  title = {Discovery of SARS‐CoV‐2 Inhibitors Featuring Novel Histidine α ‐Nitrile Motif},
  journal = {Chemistry & Biodiversity},
  year = {2023},
  doi = {10.1002/cbdv.202300957}
}
Kostenlos starten →